BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33534008)

  • 21. National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection.
    Ellis RJ; Ho JW; Schlick CJR; Merkow RP; Bentrem DJ; Bilimoria KY; Yang AD
    Ann Surg Oncol; 2020 Mar; 27(3):909-918. PubMed ID: 31691112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
    Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
    BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival impact based on hepatic artery lymph node status in pancreatic adenocarcinoma: A study of patients receiving modern chemotherapy.
    Perlmutter BC; Hossain MS; Naples R; Tu C; Vilchez V; McMichael J; Tullio K; Simon R; Walsh RM; Augustin T
    J Surg Oncol; 2021 Feb; 123(2):399-406. PubMed ID: 33159317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Care and Outcomes of Adjuvant Chemoradiation for Node-Positive Pancreatic Adenocarcinoma.
    Malakhov N; Lee A; Albert A; Lederman A; Byun J; Safdieh J; Schreiber D
    J Gastrointest Cancer; 2020 Jun; 51(2):506-514. PubMed ID: 31236851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Different Treatment Modalities on the Outcome of Pancreatic Cancer.
    Khan M; Ashraf MI; Syed AA; Hanif F
    J Coll Physicians Surg Pak; 2017 Aug; 27(8):470-474. PubMed ID: 28903837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer.
    Morita Y; Sakaguchi T; Kitajima R; Furuhashi S; Kiuchi R; Takeda M; Hiraide T; Shibasaki Y; Kikuchi H; Konno H; Takeuchi H
    BMC Cancer; 2019 May; 19(1):416. PubMed ID: 31046709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 study.
    Sinn M; Striefler JK; Sinn BV; Sallmon D; Bischoff S; Stieler JM; Pelzer U; Bahra M; Neuhaus P; Dörken B; Denkert C; Riess H; Oettle H
    J Surg Oncol; 2013 Nov; 108(6):398-402. PubMed ID: 24038103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield.
    Warschkow R; Tsai C; Köhn N; Erdem S; Schmied B; Nussbaum DP; Gloor B; Müller SA; Blazer D; Worni M
    Langenbecks Arch Surg; 2020 Feb; 405(1):43-54. PubMed ID: 32040705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma.
    Nussbaum DP; Adam MA; Youngwirth LM; Ganapathi AM; Roman SA; Tyler DS; Sosa JA; Blazer DG
    Ann Surg Oncol; 2016 Mar; 23(3):1026-33. PubMed ID: 26542590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma.
    Sanford NN; Aguilera TA; Folkert MR; Ahn C; Mahal BA; Zeh H; Beg MS; Mansour J; Sher DJ
    J Natl Compr Canc Netw; 2019 Nov; 17(11):1292-1300. PubMed ID: 31693987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
    Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
    Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
    J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
    Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
    Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen.
    Yoo C; Kang J; Kim KP; Lee JL; Ryoo BY; Chang HM; Lee SS; Park DH; Song TJ; Seo DW; Lee SK; Kim MH; Park JH; Hwang DW; Song KB; Lee JH; Kim SC
    Oncotarget; 2017 Jul; 8(28):46337-46347. PubMed ID: 28564637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world outcomes of adjuvant gemcitabine
    Kang S; Yoo C; Lee SH; Oh D; Song TJ; Lee SS; Jeong JH; Park DH; Seo DW; Park JH; Hwang DW; Song KB; Lee JH; Lee W; Kwak BJ; Hong S; Chang HM; Ryoo BY; Kim KP; Kim SC
    Ther Adv Med Oncol; 2022; 14():17588359221097190. PubMed ID: 35571606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer.
    Samawi HH; Yin Y; Lim HJ; Cheung WY
    J Gastrointest Cancer; 2018 Dec; 49(4):429-436. PubMed ID: 28674913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of adjuvant chemotherapy on outcomes in appendiceal cancer.
    Kolla BC; Petersen A; Chengappa M; Gummadi T; Ganesan C; Gaertner WB; Blaes A
    Cancer Med; 2020 May; 9(10):3400-3406. PubMed ID: 32189461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?
    Merchant NB; Rymer J; Koehler EA; Ayers GD; Castellanos J; Kooby DA; Weber SH; Cho CS; Schmidt CM; Nakeeb A; Matos JM; Scoggins CR; Martin RC; Kim HJ; Ahmad SA; Chu CK; McClaine R; Bednarski BK; Staley CA; Sharp K; Parikh AA
    J Am Coll Surg; 2009 May; 208(5):829-38; discussion 838-41. PubMed ID: 19476845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.